admin

Premiering in 2009, ABC’s entrepreneur pitch show Shark Tank has seen it all. The premise of the show, now in its 12th season, is simple: inventors and entrepreneurs pitch their products to real-life investors (called sharks). The sharks evaluate the products and decide whether to back the fledgling companies with their own money.  From alarm clocks
0 Comments
In this article SOFI Pedestrians walk by the SoFi Technologies headquarters on February 22, 2022 in San Francisco, California. Justin Sullivan | Getty Images Shares of SoFi fell sharply on Tuesday and were halted after the company accidentally released its first-quarter results early. The company said the report, which was scheduled for after market close
0 Comments
With Twitter (NYSE:TWTR) and TWTR stock facing multiple, tough threats and possessing no major positive catalysts, I recommend that investors sell the shares. Overall, the biggest threat facing Twitter and its shares is the possibility that the takeover of the company — led by Tesla (NASDAQ:TSLA) CEO Elon Musk — will not close. Such an outcome
0 Comments
Twitter (TWTR) stock is still selling for $5/share less than Elon Musk’s offer. Musk has the money lined up thanks to SpaceX. What happens after the purchase isn’t your problem. Source: rafapress / Shutterstock.com Since Elon Musk said he would buy Twitter (NYSE:TWTR) for $54.20/share, about $44 billion, shares haven’t traded over $52. Twitter opened
0 Comments
Nio (NIO) offers Tesla (TSLA) luxury without the production volumes. The company has stiff competition within China, and those competitors are now exporting. Nio will likely remain small, and investors should demand a profit. Source: Robert Way / Shutterstock.com At this point in the game, investing in Nio (NYSE:NIO) stock means investing in the Chinese
0 Comments
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments
According to short-seller Hindenburg research, Mullen Automotive (NASDAQ:MULN) may be the next electric vehicle stock debacle. The news that Hindenburg Research has Mullen Automotive in its sights is not new. The short seller revealed its findings over a month ago. But those findings are worth revisiting as the stock continues to behave with volatility. Further,
0 Comments
Global conflict and rising interest rates in the U.S. are creating undervalued bank stocks. Citigroup (C) is in the news this week for a snafu in Europe, but that shouldn’t hurt C stock in the long-term. JPMorgan Chase & Co. (JPM) is the largest of the U.S. big bank stocks. Bank of America (BAC) had
0 Comments
Medical health services company Teladoc Health (NYSE:TDOC) has seen its prognosis go from bad to worse over the past month. TDOC stock had already plunged as part of the broader selloff in speculative technology companies. However, that selloff accelerated dramatically following Teladoc’s latest earnings report, which was a disappointment on almost all fronts. The terrible
0 Comments